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Objectives: Depolarizing (hyperkalemic) solutions are widely used to pre- 
serve organs for transplantation a d for cardiac operations. We previously 
observed that exposure to hyperkalemia reduced endothelium-dependent, 
noncyclooxygenase- and non-nitric oxide-mediated relaxation. This study 
was designed to examine the mechanism of this effect with regard to K 
channels and the associated membrane potential changes. Methods: Porcine 
coronary artery rings were studied in organ chambers. After incubation of 
the tissue with 20 or 50 mmol/L doses of potassium for 1 hour, the 
endothelium-derived hyperpolarizing factor-mediated relaxation in the 
artery and the membrane hyperpolarization i  a single coronary smooth 
muscle cell were studied. Results: The endothelium-derived hyperpolarizing 
factor-mediated relaxation induced by substance P, which could be signif- 
icantly inhibited by the Ca2+-activated K channel blocker tetraethylammo- 
nium but only to a lesser extent by the adenosine triphosphate-sensitive K 
channel blocker glibenclamide, was significantly reduced. Substance P-in- 
duced hyperpolarization f the membrane potential was also significantly 
reduced by the hyperkalemic incubation with a significantly elevated 
resting membrane potential. Conclusions: Depolarizing arrest reduces 
endothelium-derived hyperpolarizing factor-mediated membrane hyperpo- 
larization and relaxation by affecting mainly the Ca2+-activated K channels 
and by depolarizing the membrane for a prolonged period. We suggest that 
this is one of the mechanisms for coronary dysfunction after exposure to 
depolarizing (hyperkalemic) ardioplegic and organ-preservation solutions 
and that, therefore, "perfect" protection of the heart or other organs should 
restore the endothelium-derived hyperpolarizing factor-related endothelial 
function. (J Thorac Cardiovasc Surg 1997;113:932-41) 
D epolarizing cardioplegia is the most common method for myocardial preservation in cardiac 
operations. Potassium (K) at high concentrations 
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(hyperkalemia) is the major depolarizing agent in 
cardioplegic solutions (usually containing a 10 to 20 
mmol/L concentration of K). In addition, hyperka- 
lemia is also a key component in organ-preservation 
solutions for transplantation such as in the Univer- 
sity of Wisconsin solution (containing a 125 mmol/L 
concentration of K). During arrest of the heart or 
the preservation period of the donor organ, the 
hyperkalemic solution directly contacts the vascular 
endothelium. The effect of cardioplegic and organ- 
preservation solutions on endothelium has, there- 
fore, been the focus of investigators in several recent 
studies. 1-5 
Despite reports regarding the detrimental effect 
of cardioplegic solutions on the coronary endothe- 
lium,1, 5 studies have suggested that crystalloid car- 
dioplegic solution does not impair endothelium- 
dependent relaxation) We further demonstrated 
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Fig. 1. Schematic diagram describing the possible pathway by which hyperkalemia may affect the 
interaction between endothelium and smooth muscle. In response to the increase of the intracellular 
(cytosolic free) calcium level, endothelial cells derive three major EDRFs (prostaglandin I2,EDNO, and 
EDHF). These EDRFs decrease the intracellular calcium concentration in the smooth muscle cell through 
different mechanisms and ultimately relax the smooth muscle cell. The mechanism of EDHF to relax 
vessels is to open K channels and hyperpolarize the membrane. Subsequently, the voltage-operated Ca 2÷ 
channels (VOC) are inhibited and therefore the Ca 2+ influx is reduced and this causes relaxation. The 
present study suggests that exposure to hyperkalemia reduces the EDHF-mediated relaxation through 
affecting Kea channels (and to a lesser extent KATe channels) and prolonged epolarization. When 
EDHF-mediated relaxation is reduced, the coronary artery may have a tendency to contract and the 
coronary vascular tone increases, cGMP, Cyclic guanosine monophosphate; cAMP, cyclic adenosine 
monophosphate; PGI> Prostaglandin 12. 
that the noncyclooxygenase pathway-mediated n- 
dothelium-dependent relaxation in porcine coro- 
nary arteries 3 and neonatal rabbit aortas 4 is not 
altered by exposure to hyperkalemia or cardioplegic 
solutions. However, most recently, we have discov- 
ered that endothelium-dependent relaxation medi- 
ated by the noncyclooxygenase nd non-nitric oxide 
pathway (that is, the endothelium-derived hyperpo- 
larizing factor [EDHF] pathway) in porcine coro- 
nary arteries is altered by exposure to hyperkale- 
mia. 6 
Endothelium-dependent relaxation is known to 
be the effect of a variety of different endothelium- 
derived relaxing factors (EDRFs). These are endo- 
thelium-derived nitric oxide (EDNO), prostacyclin 
(prostaglandin I2) , and EDHF. In contrast to 
EDNO and prostaglandin I2, the nature of EDHF 
has not been fully identified] EDHF induces vascu- 
lar smooth muscle relaxation via hyperpolarization 
of the smooth muscle cells, 8-13 which may involve 
potassium (K) channels, n-13 In contrast, EDNO 
relaxes blood vessels through the cyclic guanosine 
monophosphate pathway. 8'14 However, all of these 
EDRFs are released in response to the increase of 
intracellular (cytosolic free) calcium concentration 
in the endothelial cell. 7 
Our previous study demonstrated that in the 
porcine coronary artery precontracted by the depo- 
larizing agent K, EDHF-mediated relaxation is sig- 
nificantly reduced by exposure to hyperkalemia (K 
concentration of 20 to 50 mmol/L). 6 However, the 
mechanism is unknown. On the basis of the previous 
findings suggesting that the mechanism of EDHF is 
related to K channels 12-15 and that hyperpolariza- 
tion of the membrane potential is the direct re- 
sponse of smooth muscle to EDHF, we hypothe- 
sized that the mechanism of the observed reduction 
of EDHF-mediated relaxation is related to inhibi- 
tion of K channels and prolonged epolarization of
the smooth muscle membrane potential. Fig. 1 
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i l lustrates our proposal  with regard to the mecha- 
nism (explanation given in figure legend). 
The present study was designed to examine the 
described hypothesis. In this study, we used recep- 
tor -mediated vasoconstr ictor U46619, instead of de- 
polariz ing agent K, to precontract  the vessel with the 
presence of various K channel blockers to clarify the 
subtype of K channels involved. In addit ion, we 
directly measured the membrane potent ia l  of the 
coronary smooth muscle in response to substance P 
with regard to the exposure to hyperkalemia.  
Material  and methods 
Isometric tension studies. Coronary arteries were ob- 
tained from porcine hearts that were harvested in a local 
abattoir. Immediately after the hog (either sex) was killed, 
the heart was rapidly removed, placed in a container filled 
with Krebs solution at 4 ° C, and transferred to the labo- 
ratory within 1 hour. On receipt of the heart, epicardial 
coronary arteries were immediately dissected free from 
the surrounding connective tissue, cut into 3 mm long 
rings, and mounted on a pair of stainless teel wires in 
organ chambers ~6 filled with Krebs solution at 37 ° C. The 
Krebs solution had the following composition (in millimo- 
lars): Na + 144, K + 5.9, Ca 2+ 2.5, Mg 2+ 1.2, C1- 128.7, 
HCO 3 25, 8042- 1.2, HzPO 4- 1.2, and glucose 11. The 
solution was aerated with a gas mixture of 95% 02/5% 
CO 2 at 37 ° C. Six organ-chamber a rangements were run 
concurrently. We have previously demonstrated that en- 
dothelinm-dependent relaxation is well preserved by this 
method)'  4, 6 
A previously described organ-chamber technique I6" ~7 
was used to normalize vascular ings under physiologic 
pressure with use of a computer program (VESTAND 2.1 
by Yang-Hui He, Princeton University). 
The endothelium was intentionally preserved by cau- 
tiously dissecting and mounting the rings)' 4, e To examine 
the endothelium dependence of the relaxation to sub- 
stance P (n = 4 to 7 in each group), in some rings the 
endothelium was removed mechanically with use of a fine 
wood stick moistened with Krebs solution to gently rub 
the intima of the rings. This method has been demon- 
strated to eliminate ndothelium-dependent r laxation in 
the canine coronary artery 16 and the human internal 
thoracic artery. ~s In endothelinm-dennded rings, nitro- 
glycerin ( -4.5 log M) was added at the end of the 
experiments to test whether those rings could still be 
relaxed with this endothelinm-independent vasorelaxant 
agent.3, 16 
The protocol of these studies was as follows. All rings 
were equilibrated for 30 minutes before and after normal- 
ization. U46619 (30 nmol/L) was then added to the organ 
chamber to contract the rings. When the contraction 
reached a stable plateau (usually after 10 minutes), cumu- 
lative concentration-response curves to substance P were 
established as follows. The concentrations for substance P 
were -12  to -8  log M. 
Control. The concentration-relaxation curves were es- 
tablished with the presence of various combinations of 
inhibitors as follows: (1) indomethacin (7 /zmol/L), a 
cyclooxygenase inhibitor, and NO-nitro-L-arginine (L- 
NNA, 300 /xmol/L), a nitric oxide biosynthesis/release 
inhibitor; (2) indomethacin (7 /xmol/L), L-NNA (300 
/xmol/L), and a Caa+-activated K channel (KCa) blocker, 
tetraethylammonium (1 mmol/L); (3) indomethacin (7 
/xmol/L), L-NNA (300 /,mol/L), and an adenosine 
triphosphate-sensitive K channel (KATe) blocker, gliben- 
clamide (3 txmol/L); and (4) indometbacin (7>mol/L) and 
glibenclamide (3/xmol/L). 
In our pilot experiments, we tested the endothelial 
preservation i  two ways. First, we prolonged the time for 
the coronary preparation i the organ chamber for up to 
4.5 hours with frequent washing to simulate the situation 
after exposure to K (n = 10). Second, in the presence of 
indomethacin and L-NNA, after the first relaxation curve 
to substance P, the rings were repeatedly washed. The 
same inhibitors were then added and the artery was 
contracted with U46619 (30 nmol/L) again. The second 
substance P relaxation curve was induced (n = 6). In both 
situations, the substance P-induced relaxation showed no 
difference compared with the substance P relaxation in- 
duced without waiting for 4.5 hours (in the first situation) 
or with the first substance P-induced relaxation (in the 
second situation). This demonstrated that our careful wash- 
out technique did not impair the EDHF-mediated endothe- 
lial function and that the substance P-induced relaxation was 
reproducible in the same coronary preparation. 
Exposure to hyperkalemia. In separate experiments, 
rings were exposed to hyperkalemic solutions that con- 
tained a 20 mmol/L concentration of K in the Krebs 
solution. After exposure for 1 hour, the chamber solutions 
were changed to normal Krebs solution again and the 
rings were frequently washed with Krebs solution to 
restore the baseline conditions. The previously described 
protocols 1, 2, and 4 were repeated before the concentra- 
tion-relaxation curves to substance P were established. 
Other arteries were incubated with a 50 mmol/L con- 
centration of K in the Krebs solution. After the incuba- 
tion, protocols 1 and 4 were studied in those arteries. 
Indomethacin, L-NNA, tetraethylammonium, and glib- 
enclamide were added 30 minutes before the concentra- 
tion-relaxation curves for substance P were started. Only 
one concentration-relaxation curve was obtained for each 
coronary ring. For a number of rings in each group of 
experiments, a mean concentration-relaxation curve was 
constructed. During the experiments, the solutions in the 
organ chamber were continuously aerated with a mixture 
of 95% 02/5% CO2 at 37°C to exclude the effect of 
ischemia nd temperature. 
Electrophysiologic studies (membrane potential mea- 
surement). Porcine coronary rings were cut along the 
longitudinal axis and mounted on the bottom of a 2.5 ml 
organ bath with the intimal side upward. After 60 minutes 
of equilibrium, a glass microelectrode filled with a 3 mol/L 
concentration of KC1 (tip resistance 40 to 80 MW) was 
inserted into a smooth muscle cell from the endothelial 
side.S, 12, 14 The electrical signals were amplified by means 
of a microeleetrode amplifier (Axoprobe-lA, H.V. elec- 
trometer model 400B, Axon Instruments, Inc., Foster 
City, Calif.). The membrane potential was displayed con- 
tinuously on an oscilloscope (COS5020-ST, Gould, Cleve- 
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Table I. Precontraction force (g) induced by U46619 
Indo + L-NNA Indo + GBM Indo + L-NNA + GBM lndo + L-NNA + TEA p Value* 
Control  11.1 _+ 1.0 3.3 _+ 0.6 14.9 _+ 0.8 7.9 ± 0.9 <0.001 
K20 11.4 _+ 1.0 7.2 _+ 1.7 5.8 + 0.5 0.0001 
K50 12.4 ± 0.9 5.1 ± 0.7 <0.0001 
Indo, Indomethacin; GBM, glibenclamide; TEA, tetraethylammonium; K20, after exposure to 20 mmol/L K + for 1 hour; K50, after exposure to 50 mmol/L 
K + for 1 hour. 
*Analysis of variance among the groups with different inhibitors. 
land, Ohio) and simultaneously recorded on a tape recorder 
(PCM-2 analog/digital video cassette recorder, Medical 
System Corp., Greenvale, N.Y.). The criteria of impal- 
ing cells are a sudden negative change in voltage 
followed by a stable negative voltage for more than 1 
minute and an instantaneous return to the previous 
voltage level on dislodgment of the microelectrode. 9' i1 
Experimental protocol. After stabilization for 60 min- 
utes, concentration-response curves were established for 
substance P (-11 to -8  log M) in the presence of 
indomethacin (7/xmol/L) and L-NNA (300 /xmol/L) for 
30 minutes as the control. Pilot experiments (n = 7) 
demonstrated that the concentration-response curves, af- 
ter careful wash out (by slowly changing the bath solu- 
tion), could be repeated without significant changes. 
These pilot experiments also ruled out the possibility that 
any changes in membrane potential after exposure to K 
were caused by mechanical injury because of our wash-out 
technique. The vessel was repeatedly washed to restore 
the resting membrane potential. The artery was then 
exposed to the hyperkalemic solution (Krebs solution with 
a K concentration f20 mmol/L, which replaced the Na ÷) 
for 1 hour. During the incubation, the artery was contin- 
uously perfused at a rate of 3 ml/min and was oxygenated 
with a mixture of 95% 02/5% CO2 to exclude the effect of 
ischemia. The artery was repeatedly washed with the 
normal Krebs solution for 30 minutes. After the washout, 
indomethacin (7/xmol/L) and L-NNA (300/xmol/L) were 
added to incubate the ring for another 30 minutes and the 
concentration-response curve was established for sub- 
stance P ( -11 to -8  log M). 
Data analysis. The effective concentration of the relax- 
ation agent that caused 50% of maximal contraction (or 
relaxation) was defined as ECs0. The ECso was deter- 
mined from each concentration-relaxation curve by a 
logistic, curve-fitting equation: E = MAP/ (A  p + KP), 
where E is response, M is maximal contraction (or relax- 
ation), A is concentration, K is ECso concentration, and p 
is the slope parameter. 16From this fitted equation, the 
mean ECso value plus or minus the standard error of the 
mean was calculated for each group. 
Statistical analysis. Data were analyzed by analysis of 
variance (followed by Scheffe's test), unpaired, or paired t
test when appropriate. A value ofp < 0.05 was considered 
significant. 
Drugs. Drugs used and their sources were as follows: 
substance P, L-NNA, indomethacin, glibenclamide, and 
tetraethylammonium (Sigma, St. Louis, Mo.) and U46619 
(Cayman Chemical, Ann Arbor, Mich.). L-NNA (dis- 
solved in distilled water) and indomethacin (dissolved in 
ethanol) were stored at 4 ° C. The solution of U46619 was 
held frozen until required. Glibenclamide was dissolved in 
95% ethanol to a concentration of 1 mmol/L. In control 
experiments, ethanol did not show any effects on the 
substance P-induced relaxation at the concentration of 
0.3%, as has also been observed by others. 3' 5 
Results 
Isometric tension measurement.  The diameter of 
the vascular rings at a pressure of 100 mm Hg was 
3.3 _+ 0.2 mm and the transmural pressure was 
70.8 _+ 2.8 mm Hg at 90% of the diameter at 100 
mm Hg. 16' 17 
Basal tone. The change in the basal tone induced 
by various inhibitors was minimum. In all groups, 
indomethacin plus glibenclamide did not affect the 
tone. However, indomethacin plus L -NNA slightly 
increased the tone. In the control rings, the change 
of the tone was 0.2 _+ 0.1 gm. In the rings treated 
with a 20 mmol/L concentration of K, the change of 
the tone was also 0.2 _+ 0.1 gm. In the rings treated 
with a 50 mmol/L concentration of K, the change of 
the tone was 0.8 _+ 0.1 gin. However, tetraethylam- 
monium significantly increased the resting tone. In 
the control group, the resting tone increased by 
4.1 _+ 0.6 gm (p < 0.05) whereas in treatment with a 
20 mmol/L concentration of K, it was 4.3 + 0.8 gm 
(p < 0.05). 
Comparison of precontraction. Precontraction by 
U46619 was affected by the inhibitors. Table I gives 
details of the precontraction force. In the control 
group, after treatment with indomethacin and L- 
NNA (n = 6), the tone was 11.1 _+ 1.0 gm, whereas 
it was 3.3 _+ 0.6 gm after treatment with indometh- 
acin and glibenclamide (n = 5,p = 0.0002). Further 
addition of tetraethylammonium to indomethacin 
and L -NNA also slightly reduced the contraction by 
U46619 (7.9 _+ 0.9 gm, p = 0.09). Similar results 
were also seen in other groups (Table I). In the 
group treated with a 20 mmol/L concentration of K, 
the decrease of precontraction by indomethacin, 
L-NNA, and tetraethylammonium reached statisti- 
cal significance (5.8 _+ 0.5 gm vs 11.4 _+ 1.0 gm, p < 
0.01). 
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Fig. 2. Mean concentration-relaxation curves for sub- 
stance P (concentration: -log M; relaxation: percent of 
contraction by U46619, 30 nmol/L). Symbols represent 
data averaged from a group of rings. Vertical bars are 1 
standard error of the mean of the response at each 
concentration. I do + GBM, response in presence of indo- 
methacin (7/xmol/L) and glibenclamide (3/xmol/L) (n = 5); 
Indo + LNNA, response in presence of indomethacin (7 
/xmol/L) and L-NNA (300 ~mol/L) (n = 6); Indo + LNNA 
+ GBM, response in presence of indomethacin (7/xmol/L), 
L-NNA (300/xmol/L), and glibendamide (3/xmol/L) (n = 
6); Indo + LNNA + TEA, response in presence of indo- 
methacin (7 ~mol/L), L-NNA (300/xmol/L), and tetraethyl- 
ammonium (1 retool/L) (n = 8); E- ,  endothelium denuded 
(n = 4). Significancep < 0.0001 among the groups (analysis 
of variance). **p < 0.01; ***p < 0.0001 compared with 
indomethacin +L-NNA and indomethacin + glibenclamide 
(Scheffe's F test). 
Substance P-induced relaxation. In control rings, 
treatment with indomethacin, indomethacin plus 
L-NNA, and indomethacin plus glibenclamide did 
not change the maximal relaxation (93.9% _+ 2.2% 
without treatment vs 98.8% + 0.8% with indometh- 
acin, 93.1% + 1.8% with indomethacin plus L- 
NNA, and 97.6% -+ 1.1% with indomethacin plus 
glibenclamide; p > 0.05, analysis of variance). Fur- 
ther addition of glibenclamide to indomethacin and 
L-NNA reduced the maximal relaxation to 71.5% _+ 
5.7% (p < 0.01 compared with the control and with 
the three treatments just mentioned, Scheffe's test). 
However, the most significant reduction of the re- 
laxation was seen when indomethacin, L-NNA, and 
tetraethylammonium were present (33.6% +_ 8.8%, 
Fig. 3. Mean concentration-relaxation curves (concentra- 
tion: -log M; relaxation: percent of contraction by 
U46619 30 nmol/L) for substance P in the coronary 
arteries exposed to hyperkalemia (K 20 mmol/L) for 1 
hour. See Fig. 2 for the meaning of the symbols. Indo + 
GBM, response in presence of indomethacin (7/zmol/L) 
and glibenclamide (3 /xmol/L) (n = 6); Indo + LNNA, 
response in presence of indomethacin (7 /xmol/L) and 
L-NNA (300 /xmol/L) (n = 6); lndo + LNNA + TEA, 
response inpresence of indomethacin (7/xmol/L), L-NNA 
(300/xmol/L), and tetraethylammonium (1 retool/L) (n = 
8); E- ,  endothelium denuded (n = 4). **p < 0.01 
(Scheffe's F test) compared with the arteries treated with 
the same inhibitors but not exposed to K (see Fig. 2). 
n = 8, p < 0.01 compared with the arteries with 
indomethacin, L-NNA, and glibenclamide and p < 
0.0001 compared with all other groups, Scheffe's 
test) (Fig. 2). 
Exposure to hyperkalemia (K concentrations of
either 20 or 50 mmol/L) significantly reduced the 
maximal relaxation in the rings treated with indo- 
methacin and L-NNA. Compared with relaxation in 
the control rings not exposed to hyperkalemia 
(93.1% _+ 1.8%), in the rings exposed to a 20 
mmol/L concentration of K, the relaxation was 
reduced to 48.8% _+ 12.3% (p = 0.01, Scheffe's test, 
Fig. 3) and in the rings exposed to a 50 mmol/L 
concentration of K, the relaxation was 30.9% -+ 
10.1% (p < 0.0001, Fig. 4). In some arteries, after 
exposure to either a 20 or 50 mmol/L concentration 
of K, the EDHF-mediated relaxation was nearly 
abolished and the ECs0 was not able to be calculated 
from the fitted equation, and this implies that the 
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Fig. 4. Mean concentration-relaxation curves (concentra- 
tion: -log M; relaxation: percent of contraction by 
U46619 30 nmol/L) for substance P in the coronary 
arteries exposed to hyperkalemia (K 50 mmol/L) for 1 
hour. See Fig. 2 for the meaning of the symbols. Indo + 
GBM,, response in presence of indomethacin (7 ~mol/L) 
and glibenclamide (3 /~mol/L) (n = 6); Indo + LNNA, 
response in presence of indomethacin (7 /xmol/L) and 
L-NNA (300 txmol/L) (n = 6); E- ,  endothelinm denuded 
(n = 4). ***p < 0.0001 (Scheffe's F test) compared with 
the arteries treated with the same inhibitors but not 
exposed to K (see Fig. 2). 
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Fig. 5. An actual tracing of the membrane potential mea- 
surement in a single smooth muscle cell of the porcine 
coronary artery. Concentration-response (m mbrane poten- 
tial) curves were established for substance P in the presence 
of indomethacin (7/xmol/L) and L-NNA (300 /xmol/L) in 
the endothelium-intact artery before (a) and after (b) the 
exposure to K (20 mmol/L). This hyperpolarization is abol- 
ished in the endothelium-denuded preparation (c). 
ECs0 was so high that it was not able to be deter- 
mined by usual methods (Table II). 
In contrast, in the rings in which the cyclooxygenase 
pathway and the KATP channel were inhibited (treated 
with indomethacin and glibenclamide), the relaxation 
was not altered (compare Figs. 3 and 4 with Fig. 2). 
In endothelium-denuded rings, substance P did 
not induce any relaxation and this confirms that the 
relaxations observed in the present study were en- 
dothelium.-dependent (Figs. 2 through 4). 
Membrane potential measurement. The resting 
membrane potential was -59.3 _+ 1.1 mV (n = 6). 
Substance P-induced hyperpolarization. Substance 
P induced concentration-dependent hyperpolariza- 
tion in the coronary artery at the concentration of
-11 to -8  log M. The maximal hyperpolarization 
was -91.3 _+ 5.3 mV (n = 6). After incubation with 
K (20 retool/L) for 1 hour, the vessels were depo- 
larized to -30.8 _+ 1.8 mV (p < 0.0001). The 
arteries were repeatedly washed for 30 minutes and 
incubated with the inhibitors for another 30 minutes 
(total 1 hour) and the membrane potential still 
remained higher than the control (-56.8 _+ 1.1 mV, 
n = 6,p < 0.05). At the concentrations of -11  to -8  
log M, the substance P-induced hyperpolarization 
was significantly inhibited by the previous hy- 
perkalemic incubation (Figs. 5 and 6). The differ- 
ence was most significant at -8  log M ( -67  + 3.6 vs 
-91.3 + 5.3 mV, p = 0.003). 
Discussion 
This study has demonstrated (1) that indometha- 
cin- and L-NNA-resistant endothelium-dependent 
(EDHF related) relaxation and the associated mem- 
brane hyperpolarization in the coronary artery are 
reduced by exposure to hyperkalemia; (2) that this 
effect is vasoconstrictor independent; and (3) that 
the mechanism of this reduction of relaxation and 
hyperpolarization is related to the inhibition of Kca 
channels and prolonged epolarization i the coro- 
nary smooth muscle cells. These findings are illus- 
trated in Fig. 1. The findings from the present study, 
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Table II. ECso values (-log 3/1) for substance P-induced relaxation in presence of various inhibitors in the 
porcine coronary artery 
Indo + L-NNA Indo + GBM Indo + L-NNA + GBM Indo + L-NNA + TEA p Value* 
Contro l  10.25 + 0.20 9.9 _+ 0.08 7.36 _+ 0.06 7.65 +- 0.11 0.008 
K20 t 10.19 _+ 0.06 1 
K50 ~ 9.77 -+ 0.07 
Indo, Indomethacin; GBM, glibenclamide; TEA, tetraethylammonium; K20, after exposure to 20 mmol/L K + for 1 hour; K50, after exposure to 50 mmol/L 
K + for 1 hour. 
*Analysis of variance among the groups with different inhibitors. 
t in  some arteries, the relaxation was almost abolished so the EC50 was so high that it could not be calculated from the equation. This implies a very significant 
difference compared with the control. 
in addition to previous findings, may reveal a new 
mechanism for endothelial dysfunction after expo- 
sure to hyperkalemic cardioplegic or organ-preser- 
vation solutions and may therefore have strong 
clinical implications. 
Exposure to hyperkalemia nd EDHF-related re- 
laxation. In our studies, two other major compo- 
nents of endothelium-dependent r laxation, the cy- 
clooxygenase and EDNO pathways, were blocked by 
indomethacin a d L-NNA and, therefore, the resid- 
ual relaxation was obviously through the noncy- 
clooxygenase and non-EDNO mechanism, that is, it 
was related to the effect of EDHF. In the porcine 
coronary artery, EDHF plays a role in endothelium- 
dependent relaxation and this was partially reflected 
in our previous tudy when the arteries were pre- 
contracted by the depolarizing agent K. 6 This is even 
more significant when the coronary artery is precon- 
tracted with a receptor stimulant, U46619, as shown 
in the present study. When inhibitors for both 
cyclooxygenase and EDNO pathways were present, 
the residual relaxation was still 93% of the precon- 
traction. This suggests the role of EDHF in regulat- 
ing the coronary tone at least under the stimulated 
condition. 
In the present study, we used U46619, a throm- 
boxane A 2 mimetic vasoconstrictor, to precontract 
the coronary arteries to exclude the depolarizing 
effect of the vasoconstrictor used for precontraction. 
In our previous tudy, 6after exposure of vessels to 
hyperkalemia, precontraction was induced by the 
depolarizing agent K. However, when vessels are 
contracted by K, EDHF-mediated hyperpolariza- 
tion may be partially blocked by the K-induced 
depolarization. As shown in our studies, EDHF- 
mediated relaxation in receptor-mediated precon- 
traction (by U46619) was 93% in the present study, 
compared with only 39.7% in the K-induced precon- 
traction. 6 Our present study demonstrates that the 
reducing effect of hyperkalemia on EDHF-related, 
endothelium-dependent r laxation also exists in re- 
ceptor-mediated precontraction. This is shown by 
the observations that when cyclooxygenase and ni- 
tric oxide pathways were inhibited by indomethacin 
and L-NNA, the residual relaxation (93%) was 
reduced by the exposure to hyperkalemia to 48% 
(by K concentration f 20 mmol/L) or 30% (by K 
concentration f 50 mmol/L). Taken together with 
the results from the previous tudy, our data suggest 
that the reduction of the residual relaxation by 
hyperkalemia is not vasoconstrictor dependent. 
Therefore this effect is a uniform phenomenon 
affecting the coronary endothelium-smooth muscle 
interaction under various ituations. 
Exposure to hyperkalemia nd membrane hyper- 
polarization (electrophysiologic study). To further 
study whether the foregoing observations regarding 
relaxation were related to the effect of EDHF, in the 
present study we directly measured the membrane 
potential of the coronary smooth muscle. This was 
designed in view of the previous observation that 
EDHF-related endothelium-dependent relaxation is
coupled with the membrane hyperpolarization that 
is the reason for the use of the term EDHF. If the 
reduced relaxation is truly related to the effect of 
EDHF, the membrane potential must also be af- 
fected. The present study demonstrated a few inter- 
esting results in terms of the membrane potential. 
First, with the presence of specific inhibitors for 
both cyclooxygenase (indomethacin) and EDNO 
(L-NNA), the substance P-induced, endothelium- 
dependent relaxation was associated with hyperpo- 
larization of the membrane potential of the coro- 
nary artery smooth muscle. This result clearly 
demonstrates that the indomethacin- and L-NNA- 
resistant endothelium-dependent r laxation in the 
porcine coronary artery is mediated by EDHF. 
Second, the membrane depolarization i duced by 
exposure to hyperkalemia was prolonged (-56.8 -+ 
1.1 vs -59.3 _+ 1.1 mV, Figs. 5 and 6) even after 
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repeated washing for 30 minutes plus incubation 
with inhibitors for another 30 minutes. This pro- 
longed, partial depolarization obviously contributes 
to the reduced hyperpolarization a d relaxation in 
response to substance P. With the resting membrane 
potential higher than the usual value (partial depo- 
larization), membrane hyperpolarization is more 
difficult. 
However, the partial depolarization cannot be the 
only mechanism of the reduced EDHF-related re- 
laxation and hyperpolarization. This is because the 
reduction of the substance P-stimulated hyperpolar- 
ization in the arteries that had been exposed to 
hyperkalemia reached a greater extent (-67 + 3.6 
vs -91.3 _+ 5.3 mV, p = 0.003, Figs. 5 and 6) 
compared with the small changes in the resting 
membrane potential (-56.8 + 1.1 vs -59.3 _+ 1.1 
mV). Obviously, other mechanisms are involved 
in such a great reduction of the membrane poten- 
tial. 
K channels and the effect of hyperkalemia. K 
channels are usually subdivided according to their 
mode of activation. 19The involvement of the sub- 
type of K channels is probably species an d agonist 
dependent) Probably the relative importance of the 
three EDRFs in regulating vascular tone is also 
species dependent. Although KATe channels have 
been suggested to be involved in the hyperpolariza- 
tion of smooth muscle by EDHF, 12-14 the KCa 
channels are likely to be involved in hyperpolariza- 
tion in the coronary artery. 15 In the porcine coro- 
nary artery, EDHF is related to glibenclamide- 
insensitive K channels. 2°To examine the role of the 
Kca channels, we studied inhibitory effects of tetra- 
ethylammonium in the present study. Tetraethylam- 
monium is generally considered a specific Kca 
blocker at the concentration of less than 1 retool/ 
L, 21 although itmay be less specific for K channels at 
higher concentrations. The KATF blocker gliben- 
clamide was also applied to examine the role of 
KATe channels. 
Our experiments, by using tetraethylammonium 
and glibenclamide, demonstrated that in the porcine 
coronary artery EDHF-related relaxation mainly 
involves Kca channels, although the KATP channel 
may also be involved to a lesser extent. This is 
demonstrated by the results that tetraethylammo- 
nium, but not glibenclamide, could greatly inhibit 
the residual relaxation resistant o indomethacin 
and L-NNA (from 93% to 33%). In fact, gliben- 
clamide only slightly reduced the relaxation (to 
71.5%, Fig. 2). Therefore the present study demon- 
-50 
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Fig. 6. Membrane potential measurement of he porcine 
coronary artery. Concentration-response (membrane po- 
tential) curves were established for substance P in the 
presence of indomethacin (7 /xmol/L) and L-NNA (300 
/xmol/L). Symbols represent data averaged from six prep- 
arations in each group of coronary arteries. Vertical bars 
are 1 standard error of the mean of the response at each 
concentration. Control, without exposure tohyperkalemia; 
K20, the arteries were exposed to hyperkalemia (K 20 
mmol/L replacing Na ÷) for 1 hour before the concentra- 
tion-response curves were established; TEA, in the pres- 
ence of tetraethylammonium (1 mol/L) in addition to 
indomethacin a d L-NNA. *p < 0.05 compared with the 
control. 
strates that in the porcine coronary artery the major 
component of substance P-induced, indomethacin- 
and L-NNA-resistant (EDHF related) relaxation is
related to the opening of the gca channels. 
In summary, our experiments suggest hat the 
reduced residual relaxation described herein is cou- 
pling with the reduced hyperpolarization, that is, it is 
coupling with a reduced effect of EDHF. This may 
imply that exposure to hyperkalemia may directly 
affect the response of smooth muscle to EDHF, 
possibly through inhibiting the Kca channels. KATP 
channels may also be involved. In addition, partial 
membrane depolarization may play a role. 
We previously illustrated the possible mechanism 
of hyperkalemia on endothelial function. 6 The find- 
ings from the present study enable us to give more 
detailed suggestions on the mechanism. As shown in 
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Fig. 1, although hyperkalemia does not directly 
affect the EDNO and prostaglandin I2 pathways, it 
reduces the EDHF-related relaxation by two means. 
First, it inhibits K channels, particularly Kca chan- 
nels, similar to the effect of tetraethylammonium. 
To a lesser extent, it also affects KATP channels. 
Second, it has a prolonged epolarizing effect on the 
membrane. These actions greatly affect the hyper- 
polarizing effect of EDHF and therefore reduce 
EDHF-related relaxation and the associated mem- 
brane hyperpolarization. 
Clinical implications. As suggested before, if 
both EDNO and EDHF are active in regulating the 
tone of the coronary circulation, then the present 
study supports the proposed new mechanism for 
coronary dysfunction after exposure to hyperkale- 
mia. 6 When EDHF-mediated relaxation is reduced, 
the artery must have a higher tendency to contract 
and this may lead to coronary spasm that could be 
critical in myocardial perfusion, particularly com- 
bined with the impaired production of EDNO after 
ischemia, 2 During cardiac operations, the heart is 
arrested by perfusion of hyperkalemic cardioplegic 
solutions through the coronary circulation. Such 
exposure may reduce the vasorelaxant effect of 
EDHF during the reperfusion period even after 
washout of the hyperkalemic solution for 1 hour, as 
demonstrated in the present study. 
In addition, hyperkalemic solutions such as the 
University of Wisconsin solution (with a potassium 
concentration as high as 125 mmol/L) and Euro- 
Collins solution (with a potassium concentration of
115 mmol/L) have been widely used to preserve 
organs (heart, lung, and others). 23-26 Therefore our 
findings also have implications in organ transplan- 
tations. In addition, because ndothelium plays an 
important role in antiplatelet aggregation and pre- 
vention of atherosclerosis, the endothelial dysfunc- 
tion found in the present study may have an adverse 
effect on the long-term results of heart or other 
organ transplantation, although it is still unclear 
what the correlation is between the EDHF-medi- 
ated endothelial function and the development of 
arteriosclerosis. In fact, it has been reported that in 
cardiac allografts preserved in University of Wiscon- 
sin solution, the incidence of late graft atheroscle- 
rosis was twice as high as that in grafts preserved in 
Stanford solution. 27 The findings from the present 
study may explain, at least as one of the causes, the 
higher atherosclerotic incidence after heart trans- 
plantation with the use of University of Wisconsin 
solution. However, further studies are required to 
clarify the importance of the present findings in the 
maintenance of coronary circulation and the devel- 
opment of posttransplantation atherosclerosis. 
On the other hand, the experimental environment 
may not be exactly the same as in various clinical 
settings and therefore the application of our findings 
in clinical situations must be cautious. Furthermore, 
our study was conducted in the large coronary artery 
and we understand that there may be difference 
between the large and resistance coronary arteries 
with regard to the effect of hyperkalemia. This issue 
will be addressed in our future studies. 
We conclude that depolarizing arrest (exposure to 
hyperkalemia) reduces EDHF-mediated relaxation 
and associated membrane hyperpolarization in the 
porcine coronary artery and that this effect is vaso- 
constrictor independent. The mechanism of this 
reduction is related to the inhibition of Kca chan- 
nels, although the KATP channels may also be in- 
volved to a lesser extent, and to prolonged partial 
membrane depolarization. These findings, in addition 
to the previous findings, provide useful information for 
understanding coronary dysfunction after exposure to 
depolarizing (hyperkalemic) solutions and therefore 
have strong clinical implications. Future development 
of cardioplegic or organ-preservation s lutions hould 
restore the EDHF-related relaxation and hyperpolar- 
ization to obtain the "perfect" protection. 
We sincerely thank Dr. T. M. Wong and Dr. J. Z. Sheng 
at the Department ofPhysiology, The University of Hong 
Kong, for the kind assistance in the experiments measur- 
ing the membrane potential. 
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